KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBIT: 2015-2024

Historic EBIT for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $446.9 million.

  • Medpace Holdings' EBIT rose 26.31% to $141.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $507.0 million, marking a year-over-year increase of 24.03%. This contributed to the annual value of $446.9 million for FY2024, which is 32.67% up from last year.
  • As of FY2024, Medpace Holdings' EBIT stood at $446.9 million, which was up 32.67% from $336.8 million recorded in FY2023.
  • Medpace Holdings' EBIT's 5-year high stood at $446.9 million during FY2024, with a 5-year trough of $167.0 million in FY2020.
  • Its 3-year average for EBIT is $354.1 million, with a median of $336.8 million in 2023.
  • Data for Medpace Holdings' EBIT shows a peak YoY spiked of 40.32% (in 2022) over the last 5 years.
  • Medpace Holdings' EBIT (Yearly) stood at $167.0 million in 2020, then grew by 18.90% to $198.6 million in 2021, then soared by 40.32% to $278.7 million in 2022, then climbed by 20.86% to $336.8 million in 2023, then skyrocketed by 32.67% to $446.9 million in 2024.